Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Paul E. Gray, II, DO, FAEC, is a Staff member in the Department of Regional Practice Anesthesiology at Cleveland Clinic's Lutheran Hospital. He was appointed in 2004. Prior to that he was assistant staff and management in the Department of Anesthesiology at Lutheran Hospital and Chairman, Department of Anesthesiology Massillon Community Hospital, in Massillon, Ohio from 1991 to 2003.
Dr. Gray is licensed to practice medicine in Ohio. He is board-certified in Pediatric Advanced Life Support (PALS) and Advanced Cardiac Life Support (ACLS). He is a Fellow of the American Osteopathic College of Anesthesiologists (1991) and a Diplomat with the American Osteopathic Board of Anesthesiology.
Dr. Gray received his medical degree from Chicago College of Osteopathic Medicine in Chicago in 1980. He trained further at Brentwood Hospital, Cleveland by completing his rotation internship, a residency in anesthesiology and as chief anesthesia resident. His rotations in pediatric anesthesia were with Cleveland Clinic and Akron Children’s Hospital, Akron, Ohio.
Dr. Gray is a member of many professional societies, including American Osteopathic Association, International Anesthesia Research Society, Ohio Osteopathic Association and the District Academy of Ohio Osteopathic Association. Dr. Gray also is the Secretary and Chairman of the Budget and Finance Committee of the American Osteopathic College of Anesthesiologists.
acute postoperative pain management, ambulatory, ambulatory anesthesia, anesthesia for orthopaedic surgery, anesthesiology, anesthesiology and pain, anesthesiology practice, difficult airway management, general anesthesiology, orthopaedic, outpatient anesthesia, peripheral nerve blocks, regional anesthesia, total intravenous anesthesia, ultrasound guided nerve blocks
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/4/2016, Dr. Gray, II has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.